Healthcare / Health Information ServicesToronto
$5.45
+0.03 (+0.55%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 33% · confianza 24%
FCF escenarios
weak_data · normalized FCF $-10.1M · quality 70.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
38/100
D
Piotroski
7/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$524M
P/E
N/A
•EV/EBITDA
32.6x
↑ROE
-3.6%
↓Gross Margin
75.8%
↑Debt/Equity
0.44
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+38.6%
FCF CAGR
—
FCF margin
-15.4%
FCF / Net income
4.16x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $63.3M · net income $-2.3M · FCF $-9.8M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $63.3M | $63.3M | $48.9M | $34.2M | $23.7M |
| Net Income | $-2.3M | $-2.3M | $-7.7M | $-14.5M | $-9.1M |
| EBITDA | $15.2M | $15.2M | $6.3M | $-5.8M | $-3.2M |
| EPS | -0.02 | -0.02 | -0.09 | -0.19 | -0.12 |
| Gross Margin | 75.8% | 75.8% | 75.1% | 67.6% | 61.7% |
| Operating Margin | -13.4% | -13.4% | -12.2% | -40.7% | -41.2% |
| Net Margin | -3.7% | -3.7% | -15.8% | -42.4% | -38.5% |
| Balance Sheet | |||||
| Debt/Equity | 0.44 | 0.44 | 0.45 | 1.75 | 0.27 |
| Current Ratio | 1.41 | 1.41 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-9.8M | $-9.8M | $-10.1M | $-18.4M | $-9.8M |
| Returns | |||||
| ROE | -3.6% | -3.6% | -11.9% | -90.0% | -35.2% |
| Valuation | |||||
| EV/EBITDA | 32.64 | 32.64 | 78.15 | — | — |
| P/B | 7.96 | 7.96 | 7.98 | 14.48 | 7.51 |
| Growth & Yield | |||||
| Revenue Growth | 29.3% | 29.3% | 43.0% | 44.1% | — |
| EPS Growth | 77.8% | 77.8% | 52.6% | -58.3% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-15.5%
Start / end P/E
n/dx → n/dx
EPS bridge
-0.09 → -0.02
Residual
-15.5%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.